During the past decade, AVIX Investigación Clínica S.C conducted 14 clinical trials. In the 10-year time frame, 14 clinical trials started and 4 clinical trials were completed, i.e. on average, 28.6% percent of trials that started reached the finish line to date. In the past 5 years, 8 clinical trials started and 4 clinical trials were completed. i.e. 50% of trials that started reached the finish line.

Out of the total clinical trials conducted in "AVIX Investigación Clínica S.C" #1 sponsor was "Hoffmann-La Roche" with 8 trials, followed by "Janssen Research & Development, LLC" with 3 trials sponsored, "AstraZeneca" with 1 trials sponsored, "Boehringer Ingelheim" with 1 trials sponsored and "Janssen Pharmaceutica N.V., Belgium" with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "AVIX Investigación Clínica S.C" #1 collaborator was "Eli Lilly and Company" with 3 trials as a collaborator, "Foundation Medicine, Inc." with 1 trials as a collaborator and "Pharmacyclics LLC." with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "AVIX Investigación Clínica S.C" are "Alzheimer Disease" (3 trials), "Alzheimer's Disease" (3 trials), "Non-Small Cell Lung Cancer" (2 trials), "Cancer of Unknown Primary Site" (1 trials) and "Carcinoma, Non-Small-Cell Lung" (1 trials). Many other conditions were trialed in "AVIX Investigación Clínica S.C" in a lesser frequency.

Most popular intervention types in "AVIX Investigación Clínica S.C" are "Drug" (15 trials) and "Radiation" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (6 trials), "Atezolizumab" (3 trials), "Gantenerumab" (3 trials), "Alectinib" (2 trials) and "Bevacizumab" (2 trials). Other intervention names were less common.

The vast majority of trials in "AVIX Investigación Clínica S.C" are 12 trials for "All" genders and 3 trials for "Male" genders.

Currently, there are NaN active trials in "AVIX Investigación Clínica S.C". undefined are not yet recruiting, 6 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in AVIX Investigación Clínica S.C, undefined suspended trials, and 6 terminated clinical trials to date.

Out of the total trials that were conducted in AVIX Investigación Clínica S.C, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 13 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".